AQST · Aquestive Therapeutics, Inc.
$5.16
-0.23 (-4.27%)
At close · Aug 27
Market Cap
$676.51M
Shares
125.51M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-06-10 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| DEF 14A | 2026-04-24 | 2026-06-10 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-03-20 | 2026-03-16 | |
| 10-K | 2026-03-04 | 2025-12-31 | |
| 8-K | 2026-03-04 | 2026-03-03 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-02-02 | 2026-01-30 | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-10-08 | — | |
| 8-K | 2025-10-01 | — | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-15 | 2025-08-14 | |
| 8-K | 2025-08-14 | 2025-08-13 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-06-16 | 2025-06-13 | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-11 | |
| 8-K | 2025-04-01 | — | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-03-05 | — | |
| 10-K | 2025-03-05 | 2024-12-31 | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-19 | — | |
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-11-07 | 2024-11-01 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-10-25 | — | |
| 8-K | 2024-10-24 | — | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-09-27 | — | |
| 8-K | 2024-09-09 | — | |
| 8-K | 2024-08-14 | — |
Showing 1–50 of 188 filings
Key facts
CIK
1398733
CUSIP
03843E104
13F (30d)
161 filings
159 filers
Visit website
Investor relations